No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - The largest market purchase of shares in London on Thursday came from Oxford Biomedica's chair Roch Doliveux. who upped his stake in the cell and gene therapy company after a sharp drop in the stock over the year to date.
Doliveux, has been at the helm of the board since 2020, bought 20,250 shares at a price of 505p each, spending a total of £102,262.50.
OXB's share price closed Wednesday's session at 481p, having lost over a quarter of its value since the start of 2026.
After the latest purchase, Oxford Biomedica said Doliveux owns 459,055 shares, equivalent to 0.379% of the company's issued share capital.
Top Director Buys
Oxford Biomedica (OXB)
Director name: Doliveux,Roch
Amount purchased: 20,250 @ 505.00p
Value: £102,262.50
St James's Place (STJ)
Director name: Manduca,Paul
Amount purchased: 3,624 @ 1,097.73p
Value: £39,781.55
St James's Place (STJ)
Director name: Manduca,Paul
Amount purchased: 3,624 @ 1,097.73p
Value: £39,781.55
Trufin (TRU)
Director name: Bergh,James van den
Amount purchased: 30,000 @ 97.57p
Value: £29,271.00
Gresham House Energy Storage Fund (GRID)
Director name: Stevenson ,David
Amount purchased: 8,610 @ 98.10p
Value: £8,446.41
Activeops (AOM)
Director name: Jeffery,Richard John
Amount purchased: 73 @ 205.00p
Value: £149.65
St James's Place (STJ)
Director name: FitzPatrick,Mark
Amount purchased: 4 @ 1,125.23p
Value: £45.01
St James's Place (STJ)
Director name: Manduca,Paul
Amount purchased: 2 @ 1,125.23p
Value: £22.50